11/11
04:20 pm
snoa
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
High
Report
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
11/9
08:42 am
snoa
Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
High
Report
Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
11/7
08:45 am
snoa
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
High
Report
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
10/31
04:01 pm
snoa
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
Medium
Report
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
10/22
11:56 am
snoa
U.S. OTC Drugs Market Forecast Report 2024-2029: Shares of Key Players, Industry Trends & Statistics, and Growth Forecasts by Product Type, Formulation Type and Distribution Channel [Yahoo! Finance]
Low
Report
U.S. OTC Drugs Market Forecast Report 2024-2029: Shares of Key Players, Industry Trends & Statistics, and Growth Forecasts by Product Type, Formulation Type and Distribution Channel [Yahoo! Finance]
10/22
08:57 am
snoa
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada [Yahoo! Finance]
Medium
Report
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada [Yahoo! Finance]
10/22
08:35 am
snoa
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
Medium
Report
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
10/21
04:01 pm
snoa
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences
Medium
Report
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences
9/19
08:30 am
snoa
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
High
Report
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
9/17
08:30 am
snoa
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
High
Report
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
9/11
08:30 am
snoa
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
Low
Report
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
8/28
06:25 am
snoa
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock [Yahoo! Finance]
High
Report
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock [Yahoo! Finance]
8/28
06:10 am
snoa
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
High
Report
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
8/26
08:30 am
snoa
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff
Low
Report
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff